* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Covance

                   

Unpredictable Markets? Heed Your Own Voice (at Seeking Alpha)

yahoo.com
yesterday
        

by: Robert Freedland posted on: October 10, 2008 | about stocks: ' anyone? After spending the last five+ years on my blog repeating endlessly the mantra of 'listening to my portfolio', what did I do? In fact LDK closed at...

add comment
                   

Recession Schmession, This Industry Is On Fire (at Motley Fool)

yahoo.com
yesterday
        

No, this isn't an article about how energy or agriculture stocks are on fire. Contract research organizations (CROs) do pre-clinical research and run clinical trials for drug developers on the cheap. With pharmaceutical...

add comment
                   

Learn About the Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition

marketwire.com
Oct 9, 2008 2 related
        

LONDON, UNITED KINGDOM--(Marketwire - Oct. 9, 2008) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. Outsourcing in Drug Development:...

add comment

Pharma outsourcing: people on the move

pharmiweb.co.uk
Oct 9, 2008
        

Outsourcing-Pharma.com presents its periodic round-up of executive appointments in the contract services sector. Charles River Laboratories International has promoted Dr Christophe Berthoux to the newly-created position of...

add comment

Global Payments Rated a Hold (at Seeking Alpha)

yahoo.com
Oct 7, 2008
        

by: Robert Freedland posted on: October 07, 2008 | about stocks: I was feeling a little like Chicken Little earlier today, feeling for sure that the 'sky was falling'! All of my stocks were hitting sale points and one by one I...

add comment

Covance signs drug development services agreement with Lilly

pharmaceutical-business-review.com
Oct 7, 2008
        

Covance, a provider of drug development services, has closed its transaction with Eli Lilly and Company to provide a broad-range of drug development services over the next 10 years and to purchase Lilly's 450-acre early drug...

add comment
                   

ResMed Is Rated A Sell

istockanalyst.com
Oct 6, 2008
        

Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers...

add comment

A New Model for Pharma Research Activity

redorbit.com
Oct 6, 2008 1 related
        

By Anonymous Covance in $50 million deal to buy Eli Lilly's Indianapolis- based laboratories PHARMACEUTICAL THE BUSINESS MODEL for pharmaceutical research activity is leaving its familiar environs for a cheaper, faster and more...

add comment
                   

Covance decides to pursue its original preclinical strategy in China

antara.co.id
Oct 6, 2008
        

Princeton, N.J., (ANTARA News/PRNewswire-AsiaNet) -- Covance Inc. (NYSE: CVD) announced today that it will no longer pursue a 50-50 joint venture with WuXi Pharmatech to provide preclinical contract research services in China....

add comment

Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2008 Financial Results...

yahoo.com
Oct 3, 2008 2 related
        

Friday October 3, 11:10 am ET PRINCETON, N.J., Oct. 3 /PRNewswire-FirstCall/ -- In conjunction with its third quarter 2008 earnings release (expected to be issued after market close on October 22), Covance Inc. (NYSE: CVD -...

add comment
1 2 3 4 5 next »